https://www.news-medical.net/news/20221027/The-effectiveness-of-BNT162b2-COVID-19-vaccine-against-infection-with-SARS-CoV-2-Omicron-subvariants-BA45.aspx
0
0
10/27/22 at 1:09pm
Organization
News-Medical.Net
Authors
Researchers evaluated the vaccine effectiveness of Pfizer-BioNTech’s BNT162b2 COVID-19 vaccines against SARS-CoV-2 Omicron BA.4/5.
9 similar articles
Create an account
or login to join the discussion